Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 27M | 23M |
| Cost of revenue | 17M | 13M |
| Gross profit | 10M | 10M |
| Research and development | 1M | 961,837 |
| Selling, general and administrative | 14M | 11M |
| Operating expenses | 18M | 14M |
| Operating income | −8M | −5M |
| Pre-tax income | −8M | −5M |
| Net income | −8M | −5M |
| Earnings per share | −0.30 | −0.19 |
| Earnings per share, diluted | −0.30 | −0.19 |
| Weighted average shares | 27M | 25M |
| Weighted average shares, diluted | 27M | 25M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 9M | 12M | 15M | 2M | 4M | 5M | 1M | 841,913 |
| Receivables | 5M | 4M | 6M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −10M | 4M |
| Depreciation and amortisation | 877,675 | 553,783 |
| Share-based compensation | 348,029 | 172,987 |
| Capital expenditure | 400,781 | 969,163 |
| Investing cash flow | −464,130 | −1M |
| Financing cash flow | 17M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 7M |
| 6M |
| 6M |
| 5M |
| 5M |
| Inventory | 11M | 11M | 10M | 10M | 10M | 10M | 10M | 10M |
| Current assets | 27M | 29M | 32M | 19M | 21M | 22M | 18M | 18M |
| Property, plant and equipment | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M |
| Goodwill | 1M | 1M | 2M | 2M | 2M | 2M | 3M | 3M |
| Total assets | 34M | 37M | 41M | 28M | 30M | 31M | 27M | 27M |
| Current liabilities | 9M | 9M | 12M | 14M | 15M | 17M | 12M | 12M |
| Total liabilities | 15M | 16M | 16M | 19M | 20M | 21M | 16M | 15M |
| Equity | 20M | 22M | 25M | 9M | 10M | 10M | 11M | 12M |
| Shares outstanding | 30M | 30M | 30M | 26M | 25M | 25M | 25M | 25M |
| Shares issued | 30M | 30M | 30M | 26M | 25M | 25M | 25M | 25M |
| 1M |